医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Pharm-Olam Continues Global Expansion; Adds Full-Service Coverage in Asia-Pacific Region

2016年01月13日 AM01:47
このエントリーをはてなブックマークに追加


 

HOUSTON

Pharm-Olam International Ltd., a multi-national, full-service Clinical Research Solutions Organization to the biopharmaceutical and medical device industries, is proud to announce its expansion of Phase I-IV clinical trial services into the Asia-Pacific region.

This expansion includes the opening of legal entities in Vietnam, Philippines, South Korea, Malaysia, Thailand and Taiwan.

“In response to requests coming in from our clients, we have begun expanding our services into the Asia-Pacific region,” said Sanjiv Suri, Pharm-Olam’s Chief Executive Officer (USA). He continued, “We anticipate significant study growth in the region over the next few years, and we are now poised to guide our clients in the development process in these promising yet often overlooked markets.”

Suri added, “The successes we’ve shared have been a result of offering our clients solutions for their unique needs. Our Asia-Pacific expansion efforts will allow us to offer comprehensive and flexible solutions in a timely and efficient manner. We look forward to continuing to support our clients globally.”

For more information about Pharm-Olam and its global Phase I-IV clinical research solutions, contact info@pharm-olam.com.

About Pharm-Olam International Group

Pharm-Olam International is a multi-national Contract Research Organization (CRO) offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, Pharm-Olam focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines. For further information about Pharm-Olam, please visit www.pharm-olam.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160112006251/en/

CONTACT

Pharm-Olam International
Mark Eberhardt, +1-713-599-7350

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Nike Announces Results of the Active Schools Innovation Award in China to Fuel the Culture of Sport and Play for Chinese Youth
  • Samsung Bioepis Announces RENFLEXIS™ (infliximab-abda) Now Available in the United States
  • ニューランド・ラボラトリーズがプロセスエンジニアリング専用ラボを公開
  • 美泰上市全球最先进的人参补剂
  • SpinalCyteが新たな日本国特許を取得